News

19Jun, 2018

CIRCULOGENE’s Molecular Testing Can Potentially Improve Management of Advanced Ovarian Cancer Patients

CIRCULOGENE’s Molecular Testing Can Potentially Improve Management of Advanced Ovarian Cancer Patients Independent UAB study demonstrates potential value of company’s molecular testing in noninvasive, serial tracking of genomic changes in treatment-resistant ovarian cancer BIRMINGHAM, Ala.– [...]

29May, 2018

REQUEST FOR APPLICATIONS CIRCULOGENE – RESEARCH SAMPLE PROFILING PILOT AWARD PROGRAM

REQUEST FOR APPLICATIONS CIRCULOGENE – RESEARCH SAMPLE PROFILING PILOT AWARD PROGRAM Applications due: 5pm EST on August 1, 2018 Award announcements: anticipated by September 15, 2018 Pilot Award Details: Made possible by Circulogene, this pilot [...]

4May, 2018

Circulogene’s PD-L1 Expression Test Featured in Clinical Lab Products Magazine

In the latest feature from Clinical Lab Products magazine, experts from First Health, Banner Health and Biodesix Inc. discuss progress and challenges on the way to a blood-based assay for PD-L1. The article, "Overcoming Immune Blockade in [...]